Lucas Duda homers twice in win over Braves

10 Comments

With Lucas Duda and David Wright doing the heavy lifting for the offense, the Mets beat the Braves 4-2 this afternoon to move to 2-0 on the season.

Wright struck first in the bottom of the first inning, driving a ball to what was once his comfort zone in right-center field. While the Mets moved in the fences at Field during the offseason, this one didn’t need any help. It traveled 430 feet, clearing both the new and old fences.

Duda homered twice on the day for the first multi-homer game of his career. The first one benefited from the new dimensions, but it wasn’t a cheap one, either. It went 410 feet to right-center field. Duda’s second one, a screamer down the right field line, would have been out in any other year. It went 360 feet.

The Braves also got into the action, as Martin Prado stroked a game-tying two-run homer in the top of the fifth which traveled 345 feet to left. That one would have been a home run last year, also. And so, Citi Field hasn’t become a homer-haven overnight, but today showed that the stadium will at least play more fair, which was the intention all along.

Dickey allowed two runs over six innings while Bobby Parnell, Jon Rauch and Frank Francisco combined for three innings of scoreless relief to lock down the victory.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.